<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The phosphatidylinositol 3-kinase/AKT (PI3K/AKT) pathway plays a critical role in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We determined the expression patterns of class I PI3K catalytic subunits and evaluated their importance in the development or progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>For this purpose, expression of class I PI3K isoforms was evaluated in 82 primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and paired non-cancerous mucosa samples by qRT-PCR </plain></SENT>
<SENT sid="3" pm="."><plain>P-AKT-Ser473 and P-AKT-Thr308 expression were measured by western blot </plain></SENT>
<SENT sid="4" pm="."><plain>We found that, compared with paired non-cancerous mucosa samples, <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of p110α and p110β in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> was significantly increased to 2.02-fold (95% confidence interval [CI] 1.25-3.28 fold) and 1.76-fold (95% CI 1.19-2.60 fold), respectively; while slight differences were found regarding the expression of p110δ (0.57-fold; 95% CI 0.31-1.07 fold) and p110γ (0.97-fold; 95% CI 0.50-1.88 fold) </plain></SENT>
<SENT sid="5" pm="."><plain>Increased p110α and p110β expression correlated with <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> size, regional <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e>, and AJCC stage </plain></SENT>
<SENT sid="6" pm="."><plain>Increased p110β expression also correlated with distant <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>P-AKT-Thr308 and P-AKT-Ser473 expression showed significant direct correlations with p110α and p110β <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression </plain></SENT>
<SENT sid="8" pm="."><plain>Besides, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with p110β <z:chebi fb="2" ids="33699">mRNA</z:chebi> overexpression had a worse disease-free survival after radical surgery compared with those with <z:mpath ids='MPATH_458'>normal</z:mpath> or decreased levels (P = 0.043) </plain></SENT>
<SENT sid="9" pm="."><plain>It was, therefore, concluded that the altered p110α and p110β expression might contribute to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> development or progression </plain></SENT>
</text></document>